Literature DB >> 9624712

Differentiation in the Amsterdam methadone dispensing circuit: determinants of methadone dosage and site of methadone prescription.

M W Langendam1, H J van Haastrecht, G H van Brussel, H Reurs, A A van den Hoek, R A Coutinho, E J van Ameijden.   

Abstract

AIMS: To evaluate the Methadone Dispensing Circuit in Amsterdam by identifying determinants of methadone dosage and client characteristics in the different types of methadone programmes. DESIGN AND PARTICIPANTS: Four hundred and forty-four participants of a cohort study of drug users in Amsterdam who had consented to link data of the Central Methadone Register to the cohort data.
FINDINGS: From 1985 to 1994, methadone dosage increased from 41 to 59 mg/day. The mean methadone dosage was higher for ethnic West Europeans, Germans, older drug users, HIV-positive drug users, those with a longer duration of prostitution, current injectors, those with a longer duration of injecting, longer duration of methadone use, higher frequency of being dispensed methadone and clients of the prostitutes' and foreigners' outpatient clinic. For clients of the general practitioner, at the police station and in prison the methadone dosage was lower. We found different sets of client characteristics in those receiving methadone at the methadone outpost, the methadone bus, the prostitutes' and foreigners' outpatient clinic, the general practitioner and the outdoor addiction clinic.
CONCLUSIONS: These results indicate that the Amsterdam system is highly differentiated in a way that is largely concordant with the intended general policy on methadone treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624712     DOI: 10.1046/j.1360-0443.1998.931617.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  8 in total

1.  Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions.

Authors:  E J van Ameijden; R A Coutinho
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

2.  Estimating the number of opiate users in amsterdam by capture-recapture: the importance of case definition.

Authors:  M C Buster; G H van Brussel; W van den Brink
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial.

Authors:  Steffanie A Strathdee; Erin P Ricketts; Steven Huettner; Lee Cornelius; David Bishai; Jennifer R Havens; Peter Beilenson; Charles Rapp; Jacqueline J Lloyd; Carl A Latkin
Journal:  Drug Alcohol Depend       Date:  2005-12-20       Impact factor: 4.492

4.  [Treatment retention and evolution of clientele in a low threshold methadone substitution treatment program in Montreal].

Authors:  Michel Perreault; Marie-Christine Héroux; Noé Djawn White; Pierre Lauzon; Céline Mercier; Michel Rousseau
Journal:  Can J Public Health       Date:  2007 Jan-Feb

Review 5.  Developing a vaccine against multiple psychoactive targets: a case study of heroin.

Authors:  G Neilm Stowe; Joel E Schlosburg; Leandro F Vendruscolo; Scott Edwards; Kaushik K Misra; Gery Schulteis; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

6.  The impact of harm-reduction-based methadone treatment on mortality among heroin users.

Authors:  M W Langendam; G H van Brussel; R A Coutinho; E J van Ameijden
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

7.  Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.

Authors:  Stephen Magura; Joshua D Lee; Jason Hershberger; Herman Joseph; Lisa Marsch; Carol Shropshire; Andrew Rosenblum
Journal:  Drug Alcohol Depend       Date:  2008-10-18       Impact factor: 4.492

Review 8.  Mobile Narcotic Treatment Programs: On the Road Again?

Authors:  Frank Breve; Lisa Batastini; Jo Ann K LeQuang; Gina Marchando
Journal:  Cureus       Date:  2022-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.